Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Enjoying now or saving for later: are we predisposed to choose?

Published on: 23/02/2023 Reading time: 1 min
Une horloge avec un fond de deux couleurs

Léonie KOBAN and Hilke PLASMANN, researchers in the team "CIA: cognitive control - interoception - attention", have identified a novel brain marker using functional imaging that predicts our preference for immediate rewards over larger later rewards. This work is published in the Journal of Neuroscience.

Delay discounting (DD)

Delay discounting (DD) is a cognitive process that describes to what degree individuals are willing to wait for larger monetary pay-off that they receive in the future or whether they prefer to receive a smaller one now (e.g., 1 EUR now vs. 2 EUR in a week). The more people discount time, the more they to prefer to receive an immediate reward rather than wait for a larger reward that is only available in the future. We are all regularly faced with this type of choice: for instance, when we decide to buy some new shoes today or save to the money for a nice vacation in the summer, whether we eat a snack in the afternoon or save our appetite for dinner, and whether we go out with friends in the evening or go to bed early to be rested the next day.

DD is highly variable from one person to the next but remains stable over time for the same person. Previous studies have associated DD as a risk factor in eating disorders (obesity or anorexia), smoking, alcohol use disorder, or drug addiction.

The aim of the study conducted by the Institute's researchers was to identify a replicable machine-learning based brain marker predictive of DD and to validate it in an independent population.

 

Assessing trends in choices

To this end, 255 healthy volunteers were asked to make choices between smaller immediate and larger later rewards during a functional MRI scan. The researchers also measured the body weight and height, the percentage of fat mass, blood insulin, and glucose levels of the study participants.

 

Significant results: the brain signature of DD

The researchers from the ICM and their colleagues used a machine learning algorithm to detect a pattern of functional brain activity that could predict individual differences in delay discounting. Machine learning is a form of artificial intelligence that allows a mathematical and statistical model to predict new data based on previously analyzed data.

The results of the study showed that it was possible to predict a person’s degree of delay discounting based on their functional brain activity across different brain regions. Furthermore, the researchers found that the marker was related to individual differences in blood insulin and glucose—two metabolic markers—and that it  differed between overweight and normal weight individuals.

Future studies can test this marker in disorders characterized by impaired decision making, such as eating disorders, addictions, or neurodegenerative diseases like Alzheimer's or Parkinson's.

Sources

Koban L, Lee S, Schelski DS, Simon MC, Lerman C, Weber B, Kable JW, Plassmann H. An fMRI-based brain marker of individual differences in delay discounting. J Neurosci. 2023 Jan 18:JN-RM-1343-22. doi: 10.1523/JNEUROSCI.1343-22.2022. Epub ahead of print. PMID: 36657973.

Our news on the subject

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them ...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain ...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol ...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and ...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of ...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show ...
05.16.2024 Research, science & health
See all our news